Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AVLN
CRON
Add up to 3 more stocks
AVLN
Avalyn Pharma Inc. Common Stock
-4.66%
$25.77-1.26Delayed quote: Oct 6, 2026, 10:55 AM EDT
Market Cap
$1.14B
52W Range
$24.15 - $40.17
CRON
Cronos Group Inc.
+0.15%
$3.25+0.00Delayed quote: Oct 6, 2026, 10:54 AM EDT
Market Cap
$1.22B
52W Range
$2.28 - $3.61
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 17.97 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.87 | 1.14 |
| P/S Ratio | N/A | 5.40 |
| P/FCF Ratio | N/A | 24.46 |
| EV/EBITDA | N/A | 27.67 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 36.2% |
| Operating Margin | 0.0% | -12.0% |
| Net Margin | 0.0% | 31.0% |
| ROE | N/A | 6.5% |
| ROA | -57.2% | 5.9% |
| ROIC | -67.7% | 1.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 33.10 | 16.18 |
| Quick Ratio | 33.10 | 15.25 |
| Debt/Equity | 0.04 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.